Literature DB >> 20101637

Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations.

T Chaiworapongsa1, R Romero, J P Kusanovic, P Mittal, S K Kim, F Gotsch, N G Than, S Mazaki-Tovi, E Vaisbuch, O Erez, L Yeo, S S Hassan, Y Sorokin.   

Abstract

OBJECTIVES: To examine the relationship between abnormalities in uterine (UtA) and/or umbilical artery (UA) Doppler velocimetry and maternal plasma concentrations of soluble endoglin (sEng) in patients with pre-eclampsia (PE).
METHODS: A cross-sectional study was conducted in 135 normal pregnant women and 69 patients with PE. Patients with PE were subclassified into four groups: those who had Doppler abnormalities in both the UtA and UA, patients who had Doppler abnormalities in the UtA alone, those who had Doppler abnormalities in the UA alone, and patients without Doppler abnormalities in either vessel. Plasma concentrations of sEng were determined by enzyme-linked immunosorbent assay.
RESULTS: Among patients with PE, those with abnormal UtA and UA Doppler velocimetry had the highest median plasma concentration of sEng compared with any other group (P < 0.001, Kruskal-Wallis test). Women with PE with normal Doppler velocimetry in both vessels had the lowest median plasma concentration of sEng. There was a significant relationship between plasma concentrations of sEng and mean UtA resistance index (Spearman Rho = 0.5, P < 0.001) as well as UA pulsatility index (Spearman Rho = 0.4, P = 0.002). Multiple regression analysis suggested that Doppler abnormalities in the UtA and UA as well as gestational age at blood sampling contributed to plasma sEng concentrations (P < 0.001).
CONCLUSIONS: Abnormalities of impedance to blood flow in the UtA and UA are associated with an excess of sEng in the circulation of mothers with PE. These findings suggest that the 'antiangiogenic state' in PE is partially reflected in abnormalities of Doppler velocimetry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101637      PMCID: PMC2944768          DOI: 10.1002/uog.7491

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  50 in total

Review 1.  Subclassification of preeclampsia.

Authors:  Peter von Dadelszen; Laura A Magee; James M Roberts
Journal:  Hypertens Pregnancy       Date:  2003       Impact factor: 2.108

2.  Normal values of Pulsatility Index from fetal vessels: a cross-sectional study on 1556 healthy fetuses.

Authors:  D Arduini; G Rizzo
Journal:  J Perinat Med       Date:  1990       Impact factor: 1.901

3.  Fetal umbilical artery velocity waveforms and subsequent neonatal outcome.

Authors:  B J Trudinger; C M Cook; W B Giles; S Ng; E Fong; A Connelly; W Wilcox
Journal:  Br J Obstet Gynaecol       Date:  1991-04

Review 4.  Toxemia: new concepts in an old disease.

Authors:  R Romero; C Lockwood; E Oyarzun; J C Hobbins
Journal:  Semin Perinatol       Date:  1988-10       Impact factor: 3.300

5.  Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro.

Authors:  B Huppertz; H G Frank; F Reister; J Kingdom; H Korr; P Kaufmann
Journal:  Lab Invest       Date:  1999-12       Impact factor: 5.662

6.  Activation of leukocytes during the uteroplacental passage in preeclampsia.

Authors:  Jan Roar Mellembakken; Pål Aukrust; Mette Kløvstad Olafsen; Thor Ueland; Kjetil Hestdal; Vibeke Videm
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

7.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

9.  Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Jimmy Espinoza; Emmanuel Bujold; Yeon Mee Kim; Luis F Gonçalves; Ricardo Gomez; Samuel Edwin
Journal:  Am J Obstet Gynecol       Date:  2004-06       Impact factor: 8.661

10.  The frequency and severity of placental findings in women with preeclampsia are gestational age dependent.

Authors:  Julie S Moldenhauer; Jerzy Stanek; Carri Warshak; Jane Khoury; Baha Sibai
Journal:  Am J Obstet Gynecol       Date:  2003-10       Impact factor: 8.661

View more
  20 in total

Review 1.  The "Great Obstetrical Syndromes" are associated with disorders of deep placentation.

Authors:  Ivo Brosens; Robert Pijnenborg; Lisbeth Vercruysse; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2010-11-20       Impact factor: 8.661

2.  Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Zeynep Alpay Savasan; Juan Pedro Kusanovic; Giovanna Ogge; Eleazar Soto; Zhong Dong; Adi Tarca; Bhatti Gaurav; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-09

3.  Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia.

Authors:  Sun K Kim; Roberto Romero; Zeynep A Savasan; Yi Xu; Zhong Dong; Deug-Chan Lee; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Reprod Immunol       Date:  2012-12-24       Impact factor: 3.886

4.  The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.

Authors:  Jezid Miranda; Roberto Romero; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Tamara Stampalija; Lami Yeo; Zhong Dong; Sonia S Hassan; George P Chrousos; Philip Gold; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-19

5.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

6.  Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

Authors:  Eleazar Soto; Roberto Romero; Juan Pedro Kusanovic; Giovanna Ogge; Youssef Hussein; Lami Yeo; Sonia S Hassan; Chong Jai Kim; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-25

7.  Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.

Authors:  Piya Chaemsaithong; Roberto Romero; Adi L Tarca; Steven J Korzeniewski; Alyse G Schwartz; Jezid Miranda; Ahmed I Ahmed; Zhong Dong; Sonia S Hassan; Lami Yeo; Tinnakorn Tinnakorn
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

8.  Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.

Authors:  Amy E Whitten; Roberto Romero; Steven J Korzeniewski; Adi L Tarca; Alyse G Schwartz; Lami Yeo; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

9.  Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Josef M Cortez; Athina Pappas; Adi L Tarca; Piya Chaemsaithong; Zhong Dong; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-08

10.  The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy E Whitten; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.